Roche wins Vabysmo prefilled syringe EU approval to intensify Eylea challenge
The European Medicines Agency (EMA) has approved Roche’s Vabysmo (faricimab) in single-dose prefilled syringe form for three retinal conditions that…
Ophthalmology
-
-
Formosa and Medvisis agree on post-operative eye pain therapy
Formosa Pharmaceuticals in Taiwan has signed an exclusive licensing agreement with Medvisis Switzerland to commercialise clobetasol propionate ophthalmic suspension, 0.05%…
-
Outlook Therapeutics stock craters as the wet AMD drug fails Phase III trial
Outlook Therapeutics’ second attempt to obtain US approval for its wet age-related macular degeneration (wet AMD) therapy, Lytenava (bevacizumab-vikg) has…
-
FDA delays priority review of Neurotech’s eye cell therapy implant
Neurotech Pharmaceuticals’ eye cell therapy implant has faced a setback as the US Food and Drug Administration (FDA) has extended…
-
AAO 2024: Nanoscope Therapeutics’ MCO-010 RESTOREs vision in RP patients
On October 20, at the 128th Annual Meeting of the American Academy of Ophthalmology (AAO) 2024 in Chicago, IL, US,…
-
Glaukos eyes FDA approval for ocular therapy after Phase III win
Glaukos plans to file for US approval of its iLink corneal cross-linking therapy Epioxa (Epi-on) for treating keratoconus after the…
-
Novaliq and Laboratoires Théa announce EC approval for dry eye disease therapy
Novaliq and Laboratoires Théa have announced approval from the European Commission (EC) for Vevizye (ciclosporin 0.1% eye drops solution) for…
-
Formosa Pharma ships APP13007 ophthalmic drug to US
Formosa Pharmaceuticals has announced the first shipment of its ophthalmic asset, clobetasol propionate ophthalmic suspension 0.05% (APP13007),to the US to…
-
SIFI’s AKANTIOR gains EC approval for acanthamoeba keratitis
Italian ophthalmic company SIFI has received European Commission (EC) approval for AKANTIOR (polihexanide) to treat acanthamoeba keratitis (AK), a rare…
-
FDA approves Sandoz’s Enzeevu as Eylea biosimilar saga continues
The US Food and Drug Administration (FDA) has approved Sandoz’s Enzeevu (aflibercept-abzv), the drugmaker’s biosimilar for wet age-related macular degeneration…
